Stock comparison

DHRvsWST

Danaher CorpvsWest Pharmaceutical Services Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

DHR

Danaher Corp

$178.57

-19.79%

Life Sciences Tools & Services$135.1BNYSE
WST

West Pharmaceutical Services Inc

$309.7

+16.24%

Life Sciences Tools & Services$17.0BNYSE

60-day price, rebased to 100

DHR -20.07% · WST +34.00%

Round-by-round

DHR 3·WST 3
EdgeDHR

Valuation upside

-44.50% vs -53.90% to DCF fair value

EdgeWST

Balance-sheet strength

Altman Z 3.97 vs 12.33

EdgeWST

Fundamental quality

Piotroski 5.00 vs 7.00 (of 9)

EdgeDHR

Growth + margins

Rule-of-40 24.30 vs 21.50

EdgeWST

60-day momentum

-20.07% vs +34.00% price return

EdgeDHR

Market-cap liquidity

$135.1B vs $17.0B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onDHRorWST

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more